The CDC's Advisory Committee on Immunization Practices (ACIP) faced unusual questioning regarding vaccine safety and efficacy. New committee members, appointed amid concerns raised by HHS Secretary Robert F. Kennedy Jr., challenged data on COVID-19 hospitalization rates in children and questioned potential biases in studies. Presentations on thimerosal (a vaccine preservative) and the risks of febrile seizures after MMRV vaccination were presented, sparking debate. Despite numerous studies refuting links between thimerosal and neurodevelopmental issues, concerns remain. The CDC maintains its position that the benefits of vaccination outweigh the risks.

Prepared by Olivia Bennett and reviewed by editorial team.